Epilepsy

Major deal for TransForm

Major deal for TransForm

Formulation specialist TransForm Pharmaceuticals has licensed a
novel salt form of the antiepileptic drug topiramate to Johnson
& Johnson in a development that provides the first real
validation of its business model.